Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford COVID-19 vaccine to begin phase II/III human trials

Clinical Trials Vaccinology

Oxford Vaccine Group researchers have begun recruiting for the next phase in human trials of a COVID-19 vaccine in human volunteers.

Paediatrics professor honoured by the Academy of Medical Sciences

The Academy of Medical Sciences, the independent body in the UK representing the diversity of medical science, has announced the election of fifty new Fellows, including Professor Matthew Wood from the Department of Paediatrics.

HIV study explains immunological differences between sexes

HIV

How can researching a cohort of infants from KwaZulu-Natal in South Africa help explain differing HIV susceptibility of males and females? Professor Philip Goulder, head of the HIV Research Group, discusses the Baby Cure study.

Landmark partnership announced for development of COVID-19 vaccine

The University of Oxford has today announced an agreement with the UK-based global biopharmaceutical company AstraZeneca for the further development, large-scale manufacture and potential distribution of the COVID-19 vaccine candidate currently being trialled by the Oxford Vaccine Group.

Oxford COVID-19 vaccine begins human trial stage

Recruitment Research Vaccinology

University of Oxford researchers have begun testing a COVID-19 vaccine in human volunteers in Oxford today. Around 1,110 people will take part in the trial, half receiving the vaccine and the other half (the control group) receiving a widely available meningitis vaccine.

Paediatrics project receives funding to assess novel coronavirus infection rates in children and teenagers across the UK

Awards & Appointments Vaccinology

A multi-site project, called ‘What’s the STORY?’ has received funding from UK Research and Innovation (UKRI) to assess novel coronavirus infection rates in children and teenagers across the UK. Given the importance of this study to the national Covid-19 response it has been deemed a priority study for the National Institute for Health Research’s (NIHR) Urgent Public Health Response.

Funding for new COVID-19 studies awarded to OVG's project on infectious disease immunity in children

Awards & Appointments Research Vaccinology

Five projects from across Oxford University's Medical Sciences Division, including a project led by Professor Matthew Snape from the Oxford Vaccine Group, are among twenty-one new studies into the novel coronavirus which have been funded by the UK government.

Visualising COVID-19 outbreak

Neuroimaging Research Research Methods

Paediatric Neuroimaging researcher provides real-time case information on epidemiological data from the COVID-19 outbreak.

Oxford COVID-19 vaccine programme opens for clinical trial recruitment

Research Vaccinology

University of Oxford researchers working in an unprecedented vaccine development effort to prevent COVID-19 have started screening healthy volunteers (aged 18-55) today for their upcoming ChAdOx1 nCoV-19 vaccine trial in the Thames Valley Region. The vaccine based on an adenovirus vaccine vector and the SARS-CoV-2 spike protein is already in production but won’t be ready for some weeks still.

Sharing the benefits

Athena Swan Neuroimaging Parents & Carers University

At the beginning of the year our family leave policies were updated. Employees can now take up most of our family leave schemes from the first day of employment, meaning that more parents can now enjoy the benefits of our generous provisions. Hayriye Cagnan from the Nuffield Department of Clinical Neurosciences, and husband Eugene Duff from the Department of Paediatrics, discuss their experience of shared parental leave following baby Ida’s arrival ten months ago.

COVID-19 vaccine development

Research Vaccinology

A vaccine candidate for COVID-19 has been identified by researchers from the Oxford Vaccine Group and Oxford's Jenner Institute.

Communicating the messages of extracellular vesicles to the wider public

Public Engagement

Wood Group researchers in the Department of Paediatrics collaborate with DPAG's Denis Noble to produce innovative podcast talks on a prominent global platform, the Future Tech Podcast. Following the release of the final podcast talk in February 2020, we chart the story leading to these innovative pieces of public engagement.

Alice in Typhoidland: Join Lewis Carroll’s Alice on a journey through the story of typhoid, from Victorian sewer systems to cutting-edge scientific research

Public Engagement Vaccinology

A new exhibition tells the story of Oxford’s role in the fight against typhoid, from pioneering efforts to eliminate typhoid in the era of Lewis Carroll’s Alice in Wonderland to game-changing present-day vaccine trials

Harrington Rare Diseases Scholar Award

FUNDING ALERT: The Harrington Discovery Institute are welcoming proposals to advance innovative research in the rare disease space. Deadline: Monday 2 March

IDRM ground-breaking – work gets underway!

Department Immunology

Work will shortly be underway on the new IMS-Tetsuya Nakamura Building, home to the new Institute of Developmental and Regenerative Medicine at Old Road Campus. The formal ground-breaking ceremony, which took place towards the end of last year, was organised by the Department of Paediatrics in collaboration with the Medical Sciences Development team.

Typhoid vaccine over 81% effective in tackling disease in Nepal

Research Vaccinology

A large field study of typhoid conjugate vaccine (TCV) in Nepal has shown a single dose to be safe and effective in reducing typhoid in children aged 9 months to <16 years in an endemic setting.

A new research centre tackles neuromuscular diseases

Awards & Appointments Children's Health

The launch of the MDUK Oxford Neuromuscular Centre marks an exciting new stage in the partnership between Muscular Dystrophy UK and the University of Oxford, with the goal of delivering new experimental medicines and developing enhanced clinical trial capacity in adult and paediatric neuromuscular diseases.

New design of ‘bike helmet’ style brain scanner used with children for first time

Neuroimaging Publication Research Methods

A new wearable ‘bike helmet’ style brain scanner, that allows natural movement during scanning, has been used in a study with young children for the first time. This marks an important step towards improving our understanding of brain development in childhood.

International neglect of typhoid outside rich countries threatens a new global health emergency

Vaccinology

The emergence of untreatable strains of typhoid threatens a new global health emergency that requires urgent collective action, argue experts from Paediatrics and the Oxford Martin School in Clinical Infectious Diseases.

Is mandatory vaccination the best way to tackle falling rates of childhood immunisation?

Public Engagement Vaccinology

Following the publication of figures showing UK childhood vaccination rates have fallen for the fifth year in a row, researchers from Paediatrics and the Oxford Martin Programme on Collective Responsibility for Infectious Disease discuss possible responses.

Load More